ARTICLE | Clinical News
Seroquel XR quetiapine fumarate regulatory update
May 12, 2008 7:00 AM UTC
AstraZeneca submitted an sNDA to FDA for Seroquel XR quetiapine to treat generalized anxiety disorder (GAD). The sustained-release formulation of the dibenzothiazepine atypical antipsychotic is approv...